# Weight Loss Study: Genetics and Response to Naltrexone/Bupropion

> **NCT05919797** · PHASE4 · RECRUITING · sponsor: **Columbia University** · enrollment: 120 (estimated)

## Conditions studied

- Obesity

## Interventions

- **DRUG:** Naltrexone-Bupropion Combination

## Key facts

- **NCT ID:** NCT05919797
- **Lead sponsor:** Columbia University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-06-08
- **Primary completion:** 2027-06-30
- **Final completion:** 2027-06-30
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2025-05-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05919797

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05919797, "Weight Loss Study: Genetics and Response to Naltrexone/Bupropion". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05919797. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*